A device that analyzes blood levels of prostate-specific antigen (PSA) is one of the first doctor’s-office uses of microfluidics–technology that can manipulate fluids on a chip at microscopic scales. When a cartridge bearing a blood sample is inserted into the tabletop device, an accurate reading can be completed in 15 minutes, helping monitor the health of patients with prostate cancer. The procedure used now involves sending a sample to a lab for analysis, which often takes a day or two. The device received European approval in June.
Credit: Christopher Harting
Product: Claros DX 1
Cost: To be announced in late 2010
Availability: Late 2010 in selected European markets
Subscribe to Continue Reading
Uh oh–you've read all five of your free articles for this month.
Insider Online Only
$19.95/yr US PRICE
Artificial Pancreas Is First To Raise $1 Million Under New Crowdfunding Rules
When Beta Bionics needed idealistic investors it found them on the Web.
Poll on Human Enhancement Shows Divided Public
A majority of Americans oppose futuristic biological enhancements that would make them smarter or stronger.
Olympians Look for an Edge with Brain Stimulation
Despite the lack of peer-reviewed evidence, startup Halo Neuroscience says its brain-zapping headphones have helped athletes get more from their training.